Inotiv, Inc. is a contract research company, which is engaged in providing nonclinical and analytical drug discovery and development services to the pharmaceutical and medical device industries and selling a range of research-quality animals and diets to the same industries, as well as academia and government clients. Its products and services focus on bringing new drugs and medical devices through the discovery and preclinical phases of development. It operates through two segments: Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). The DSA segment supports the discovery, nonclinical development and clinical development needs of researchers and clinicians for primarily small molecule drug candidates, as well as biotherapeutics and biomedical devices. The RMS segment offer access to a range of small and large research models for basic research and drug discovery and development, as well as specialized models for specific diseases and therapeutic areas.
종목 코드 NOTV
회사 이름Inotiv Inc
상장일Nov 25, 1997
CEOMr. Robert W. Leasure, Jr.
직원 수1977
유형Ordinary Share
회계 연도 종료Nov 25
주소2701 Kent Ave
도시WEST LAFAYETTE
증권 거래소NASDAQ Capital Market Consolidated
국가United States of America
우편 번호47906-1382
전화13174634527
웹사이트https://www.inotiv.com/
종목 코드 NOTV
상장일Nov 25, 1997
CEOMr. Robert W. Leasure, Jr.
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.

데이터 없음